FOLR2 and triple-negative breast carcinoma: Recently, Guimarães et al demonstrated that FRβ-expressing macrophages correlate with poor clinical outcomes in ovarian and triple-negative breast cancers, and they also found a specific macrophage population co-expressing FRβ and PD-L2.8